I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Salcedo-Magguilli, Margarita
13
results:
Search for persons
X
Format
Online (13)
Mediatypes
Articles (Online) (4)
OpenAccess-fulltext (9)
Sorted by: Relevance
Sorted by: Year
?
1
Evaluation of the efficacy and safety of TREM-1 inhibition ..:
François, Bruno
;
Lambden, Simon
;
Garaud, Jean-Jacques
...
eClinicalMedicine. 60 (2023) - p. 102013 , 2023
Link:
https://doi.org/10.1016/..
?
2
Rationale and protocol for the efficacy, safety and tolerab..:
Francois, Bruno
;
Lambden, Simon
;
Gibot, Sebastien
...
BMJ Open. 11 (2021) 7 - p. e042921 , 2021
Link:
https://doi.org/10.1136/..
?
3
sTREM-1 is a specific biomarker of TREM-1 pathway activatio:
Jolly, Lucie
;
Carrasco, Kévin
;
Salcedo-Magguilli, Margarita
...
Cellular & Molecular Immunology. 18 (2021) 8 - p. 2054-2056 , 2021
Link:
https://doi.org/10.1038/..
?
4
Nangibotide in patients with septic shock: a Phase 2a rando..:
François, Bruno
;
Wittebole, Xavier
;
Ferrer, Ricard
...
Intensive Care Medicine. 46 (2020) 7 - p. 1425-1437 , 2020
Link:
https://doi.org/10.1007/..
?
5
sTREM-1 is a specific biomarker of TREM-1 pathway activatio:
Jolly, Lucie
;
Carrasco, Kévin
;
Salcedo-Magguilli, Margarita
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8322270/. , 2021
Link:
http://www.ncbi.nlm.nih...
?
6
Rationale and protocol for the efficacy, safety and tolerab..:
Francois, Bruno
;
Lambden, Simon
;
Gibot, Sebastien
...
boreal:259148. , 2021
Link:
http://hdl.handle.net/20..
?
7
Rationale and protocol for the efficacy, safety and tolerab..:
Francois, Bruno
;
Lambden, Simon
;
Gibot, Sebastien
...
https://www.repository.cam.ac.uk/handle/1810/326575. , 2021
Link:
https://www.repository.c..
?
8
Rationale and protocol for the efficacy, safety and tolerab..:
Francois, Bruno
;
Lambden, Simon
;
Gibot, Sebastien
...
boreal:259148. , 2021
Link:
http://hdl.handle.net/20..
?
9
sTREM-1 is a specific biomarker of TREM-1 pathway activatio:
Jolly, Lucie
;
Carrasco, Kévin
;
Salcedo-Magguilli, Margarita
...
boreal:259153. , 2021
Link:
http://hdl.handle.net/20..
?
10
sTREM-1 is a specific biomarker of TREM-1 pathway activatio:
Jolly, Lucie
;
Carrasco, Kévin
;
Salcedo-Magguilli, Margarita
...
boreal:259153. , 2021
Link:
http://hdl.handle.net/20..
?
11
Nangibotide in patients with septic shock: a Phase 2a rando..:
François, Bruno
;
Wittebole, Xavier
;
Ferrer, Ricard
...
boreal:242176. , 2020
Link:
http://hdl.handle.net/20..
?
12
Nangibotide in patients with septic shock: a Phase 2a rando..:
François, Bruno
;
Wittebole, Xavier
;
Ferrer, Ricard
...
boreal:242176. , 2020
Link:
http://hdl.handle.net/20..
?
13
Rationale and protocol for the efficacy, safety and tolerab..:
Pierre-François Laterre
;
Stephan Witte
;
Jean-Marie Grouin
...
https://bmjopen.bmj.com/content/11/7/e042921.full. , 2021
Link:
https://doi.org/10.1136/..
1-13
